Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer

MLA

Butt, Julia, et al. Antibody Responses to Fusobacterium Nucleatum Proteins in Prediagnostic Blood Samples Are Not Associated with Risk of Developing Colorectal Cancer. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1234647847&authtype=sso&custid=ns315887.

APA

Butt, J., Jenab, M., Pawlita, M., Overvad, K., Tjonneland, A., Olsen, A., Boutron-Ruault, M.-C., Carbonnel, F., Mancini, F. R., Kaaks, R., Kühn, T., Boeing, H., Trichopoulou, A., Karakatsani, A., Palli, D., Pala, V. M., Tumino, R., Sacerdote, C., Panico, S., … Hughes, D. J. (2019). Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer.

Chicago

Butt, Julia, Mazda Jenab, Michael Pawlita, Kim Overvad, Anne Tjonneland, Anja Olsen, Marie-Christine Boutron-Ruault, et al. 2019. “Antibody Responses to Fusobacterium Nucleatum Proteins in Prediagnostic Blood Samples Are Not Associated with Risk of Developing Colorectal Cancer.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1234647847&authtype=sso&custid=ns315887.